Hartalega stock reports MYR 605.8 million in Q1 revenue

Published on 10/04/2026 at 20:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Hartalega stock delivered MYR 70.03 million in net income for the quarter ended June 30, 2026, up from MYR 40.47 million. Fifteen analysts hold a consensus view.

Hartalega, MYL5168OO009, Illustration mit AI erstellt.

Hartalega stock (ISIN MYL5168OO009) was last at MYR 1.04 on Bursa Malaysia on October 2, 2026, while the company reported MYR 605.8 million in revenue for the quarter ended June 30, 2026. The latest figures show a sharp improvement in profitability, but analyst caution remains part of the investment case.

Profit rises faster than revenue

According to Investing.com, Hartalega reported earnings per share of MYR 0.02 and revenue of MYR 605.8 million for the quarter ended June 30, 2026, with the results published on August 4, 2026.

The revenue figure increased 17.5 percent from MYR 515.4 million in the preceding quarter. Net income rose from MYR 40.47 million to MYR 70.03 million, an increase of 73.1 percent, according to Investing.com.

Analyst caution stays visible

The latest company figures are being weighed against a more cautious broker view. As The Edge Malaysia reported on October 2, 2026, Macquarie downgraded Hartalega to Underperform from Neutral and cut its price target from MYR 5.74 to MYR 4.32. The report also cited an average target of MYR 5.17 and a forecast range of MYR 3.80 to MYR 6.60.

Investing.com lists a Hold consensus from 15 analysts, including 4 Buy ratings, 10 Hold ratings and 1 Sell rating. Its average 12-month target is MYR 1.21, with a high of MYR 1.73 and a low of MYR 0.89, according to Investing.com.

Stock remains below yearly high

At MYR 1.04 on October 2, 2026, Hartalega stood 24.64 percent below its 52-week high of MYR 1.38 and 30 percent above its 52-week low of MYR 0.80. The session volume was 8,117,000 shares, and the market capitalization was MYR 3.5 billion.

The operating picture is therefore improving from the June quarter, while the share valuation still reflects a market divided between stronger margins and persistent pressure on glove pricing. Hartalega manufactures latex and nitrile gloves for healthcare and industrial customers across international markets.